Fox Chase Cancer Center News

PHILADELPHIA (December 22, 2022)—The Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center are pleased to announce the hiring of Lucia Borriello, PhD, as an assistant professor in the Department of Cancer and Cellular Biology at Temple. In addition to her primary position at Temple, Borriello will hold a dual appointment in the Cancer Signaling and Epigenetics research program at Fox Chase.

PHILADELPHIA (December 22, 2022)—Research has shown that human immune function is highly correlated with the microorganisms living in the gastrointestinal tract. These microorganisms, known as the microbiome, can consequently impact whether a patient develops cancer and how they respond to treatment.

PHILADELPHIA (December 20, 2022)—Joining a list of over 100 previous orators, Robert Uzzo, MD, MBA, FACS, president and CEO of Fox Chase Cancer Center, delivered the Rhoads Oration for the Philadelphia Academy of Surgery this month at The College of Physicians of Philadelphia.

PHILADELPHIA (December 16, 2022)—Kidney cancer is the 14th most common cancer worldwide and 9th among men. As such, considerable research has been conducted to improve detection, treatment, and prevention of it in the last two decades.

PHILADELPHIA (December 12, 2022)—Billy Truong, a doctoral candidate at Fox Chase Cancer Center, was awarded the American Society of Hematology (ASH) Abstract Achievement Award for a poster that he presented at the 64th ASH Annual Meeting and Exposition.

PHILADELPHIA (December 8, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of psychologist Lauren A. Rosenberg, PhD, as an assistant clinical professor in the Section of Psychiatry.

PHILADELPHIA (December 7, 2022)—Racial disparities in head and neck cancer (HNC) survival are well documented, with Black patients experiencing twice the mortality rate of whites. Previous research has shown that demographic factors like socioeconomic status and access to healthcare play a role. A study published today by researchers at Fox Chase Cancer Center suggests that independent of these factors, race itself may predict disparate outcomes between patients.

PHILADELPHIA (December 7, 2022)—Swayam Prabha, MBA, PhD, a member of the Cancer Signaling and Microenvironment research program at Fox Chase Cancer Center, was recently awarded a $792,000 American Cancer Society research scholar grant to investigate new methods for treating lung cancer.